Loomis, Sayles & Company
AGL icon

Loomis, Sayles & Company’s Agilon Health AGL Stock Holding History

Loomis, Sayles & Company’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11
Closed -$3K – 700
2023
Q4 		$3K Sell
11
-9
-45% -$3.26K ﹤0.01% 919
2023
Q3 		$9K Buy
20
+15
+300% +$6.78K ﹤0.01% 794
2023
Q2 		$2K Sell
5
-105
-95% -$59K ﹤0.01% 938
2023
Q1 		$65K Buy
110
+65
+144% +$36.4K ﹤0.01% 583
2022
Q4 		$18K Sell
45
-38
-46% -$17.8K ﹤0.01% 726
2022
Q3 		$49K Buy
83
+80
+2,667% +$47.9K ﹤0.01% 573
2022
Q2 		$2K Buy
+3
New +$1.52K ﹤0.01% 798

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company's AGL Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 11 shares — an estimated $3K sold.

Loomis, Sayles & Company first reported a position in AGL in Q2 2022 and held it in 7 quarters. The position peaked at $65K in Q1 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Loomis, Sayles & Company reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 11 Agilon Health shares in Q1 2024, an estimated $3K.
  • Loomis, Sayles & Company first reported a position in Agilon Health in Q2 2022 and held it in 7 quarters.
  • Loomis, Sayles & Company's Agilon Health position peaked at $65K in Q1 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.